Arcticzymes Technologies ASA
OSE:AZT

Watchlist Manager
Arcticzymes Technologies ASA Logo
Arcticzymes Technologies ASA
OSE:AZT
Watchlist
Price: 16.1 NOK -2.13% Market Closed
Market Cap: 822.2m NOK

Gross Margin
Arcticzymes Technologies ASA

94.3%
Current
95%
Average
64.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
94.3%
=
Gross Profit
98.4m
/
Revenue
104.4m

Gross Margin Across Competitors

Arcticzymes Technologies ASA
Glance View

Market Cap
814.2m NOK
Industry
Biotechnology

ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. The company is headquartered in Tromso, Troms. The company went IPO on 2005-11-04. The firm focuses on new solutions within molecular research, in vitro diagnostics and therapeutics. Arcticzymes Technologies ASA invests in BetaGlucans, which develops immunomodulating beta-glucan products, serving several different market segments including wound care, animal and consumer health and adjuvants.

AZT Intrinsic Value
18.13 NOK
Undervaluation 11%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
94.3%
=
Gross Profit
98.4m
/
Revenue
104.4m
What is the Gross Margin of Arcticzymes Technologies ASA?

Based on Arcticzymes Technologies ASA's most recent financial statements, the company has Gross Margin of 94.3%.

Back to Top